Dagfinn Steinar Øgreid • 1956 • Sandnes • 14 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
L LIMONA AS	Managing Director/CEO	455,000	228,522	100 % indirectly
F FLOKKI AS	Managing Director/CEO	5,322	-634,095	48.76 % indirectly
C COLOALERT AS	Managing Director/CEO	-	3,864,575	33.33 % indirectly
U UNI TARGETING RESEARCH AS	Managing Director/CEO	2,523,951	2,480,972	31.3 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
L LIMONA AS	Chairman	455,000	228,522	100 % indirectly
C CITRON AS	Chairman	192,000	7,947,722	100 % directly
F FLOKKI AS	Chairman	5,322	-634,095	48.76 % indirectly
C COLOALERT AS	Board Member	-	3,864,575	33.33 % indirectly
M MOSAIC ONCOLOGY AS	Chairman	123,966	3,477	33.33 % indirectly
U UNI TARGETING RESEARCH AS	Chairman	2,523,951	2,480,972	31.3 % indirectly
E EUROPEAN ONCOLOGY LAB AS	Board Member	93,500	-27,130	31.3 % indirectly
N NORDIC DIAGNOSTICS AS Closed	Chairman	-	29,004	30 % indirectly
N NORDISK FEDERASJON FOR MEDISINSK UNDERVISNING (NFMU)	Chairman	-	-	-
K KOLIBRI MEDICAL GROUP AS Closed	Contact Person	-	-44,335,703	-

Last update: Feb 27, 2025

Related industries3

Direct relationships5

Shares owned by Dagfinn Steinar Øgreid

Name	Share class	Total operating income	Total equity	Share
C CITRON AS	Ordinære aksjer	192,000	7,947,722	100 % directly
L LIMONA AS		455,000	228,522	100 % indirectly
F FLOKKI AS		5,322	-634,095	48.76 % indirectly
C COLOALERT AS		0	3,864,575	33.33 % indirectly
M MOSAIC ONCOLOGY AS		123,966	3,477	33.33 % indirectly
E EUROPEAN ONCOLOGY LAB AS		93,500	-27,130	31.3 % indirectly
U UNI TARGETING RESEARCH AS		2,523,951	2,480,972	31.3 % indirectly
N NORDIC DIAGNOSTICS AS Closed		0	29,004	30 % indirectly
L LEGELISTEN.NO AS		2,562,832	220,323	4.14 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025